MarketResearchReport2021

Gene Therapy Market Gene Therapy Marke t is expected to rise at a CAGR of 19.10%, with a value of USD 3.22 billion by 2030. The gene therapy market refers to the development and commercialization of therapeutic products that use genetic material to treat or prevent diseases. Gene therapy involves the introduction of genetic material, such as DNA or RNA, into cells to correct or modify their function. The goal of gene therapy is to treat the underlying genetic cause of a disease, rather than just managing its symptoms. The global gene therapy market has been growing rapidly in recent years, driven by advances in gene editing technologies, an increasing understanding of genetic diseases, and the potential for gene therapy to provide a one-time cure for certain diseases. Gene therapy involves therapies that target the genetic root cause of a disease and eradicate the disease at this base level. The system is focused on the use of introduced nucleic acids as an alternative to dru

Medical Billing Outsourcing Market The medical billing outsourcing market is expected to reach USD 29.3 billion by 2030 at 11.2% CAGR during the forecast period 2022-2030 The medical billing outsourcing market is a growing industry that provides a range of services related to medical billing and coding to healthcare providers. The market includes companies that offer revenue cycle management services, coding and documentation services, claims management, and other related services. The demand for medical billing outsourcing services is being driven by several factors, including increasing healthcare costs, the need for more efficient and effective billing processes, and the growing complexity of medical billing regulations. Major Growth Boosters and Challenges Medical billing software and solutions help healthcare billers as well as coders offer efficient administrative services to customers and file claims that provide a host of benefits including reduced errors, accurate

ENT Devices Market The ENT Devices Market Size was valued at USD 19.4 billion in 2022 and is projected to grow from USD 20.60 Billion in 2023 to USD 29.56 billion by 2030 . The ENT (Ear, Nose, and Throat) devices market refers to the industry involved in the production and distribution of medical devices used to diagnose and treat conditions related to the ear, nose, and throat. These devices include a wide range of products such as diagnostic devices, hearing aids, surgical instruments, implants, and others. The ENT devices market has seen steady growth in recent years, driven by factors such as an aging population, increasing prevalence of ear, nose, and throat disorders, and advances in technology. Market Research Future (MRFR) revealed the market is banking on treatment for sinusitis, demand for the cosmetic ENT procedures, hike in the use of favorable reimbursement policies, better support from the academic and government sectors, and others. Rising geriatric population

Telemedicine Market Telemedicine is the use of telecommunication and information technologies to provide healthcare services remotely. It includes various healthcare services such as consultations, diagnoses, treatment, and monitoring of patients. The telemedicine market has been rapidly growing due to technological advancements and increased adoption of telemedicine services. The telemedicine market was valued USD 67.3 Billion in 2021 and is expected to surpass the value of over USD 405.93 Billion by the year 2030 while registering a CAGR of 22.1% during the forecast period 2022-2030. The market can be segmented based on type, application, and region. Based on type, the telemedicine market can be segmented into real-time telemedicine, store-and-forward telemedicine, and remote patient monitoring. Real-time telemedicine involves the use of live video conferencing to provide healthcare services, while store-and-forward telemedicine involves the exchange of medical information b

AI in Drug Discovery Market The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. AI in Drug Discovery Market is expected to hold a value of about USD 8.9 Billion by 2030, and it is projected to register a CAGR of 24.9% from 2022 to 2030. In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019. Major Key Players: Players leading the global   AI in Drug Discovery Market Players ar

Fertility Services Market Global Fertility Services Market is expected to register a CAGR of 6.00% during the forecast period and hit USD 46.06 billion by 2030. . Fertility services are procedures or treatments incorporated to cure genetic and fertility issues and assist in conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family. The declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity and the consumption of alcohol/cigarettes lead to infertility, which is eventually driving the market for fertility services. According to ESHRE, more than 25 million European Union (EU) citizens are affected by infertility. In France, reimbursement/state funding includes six IUI’s (one IUI per menstruation cycle) and four IVF treatments

Microfluidic Devices Market Microfluidic device, simply put, is a technology which enables the integration of several medical tests on one chip. This has turned into a crucial technology for parallelization, miniaturization, industrialization, and integration of numerous tests in diagnostics, biological research, and drug development. Microfluidic Devices Market Size is expected to reach USD 1,820.0 Million by 2030 at 17.20% CAGR during the forecast period 2022-2030 Various factors are propelling the microfluidic devices market growth. These factors, according to the latest MRFR report, include the rise in demand for point of care testing products, growing demand in proteomics and genomics, miniaturization of chips, liquid biopsies, personalized medicine, and organ-on-a-chip. Additional factors pushing market growth include rising use in drug delivery systems, especially inhalers and insulin pumps and growing awareness of the benefits of microfluidic devices. On the contrary,